Now Available: Vetoryl Flavoured Tablets For Dogs

02 June 2025

Vetoryl Flavoured Tablets for Dogs are now available for the treatment of Canine Cushing’s syndrome.

Our new Vetoryl Flavoured Tablets for Dogs are hydrolysed chicken flavoured tablets featuring SmartTab^TM technology which allows the tablets to be easily divided into halves or quarters, ensuring flexible dosing options. Our tablets are available in 20, 30 and 60mg strengths. These will be available alongside the current Vetoryl 5mg, 10mg, 30mg, 60mg and 120mg hard capsules and come in packs of 30 tablets.

Vetoryl contains Trilostane as its active ingredient and is licensed for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism (Cushing’s Syndrome) in dogs. It has been on the market for 20 years with over 300 million capsules sold since its launch and is supported by a combination of Dechra’s extensive technical endocrinology experience and its comprehensive support initiatives.

For more information or to make a general enquiry please click the button below.

Get in Touch

^{Vetoryl contains Trilostane UK: POM-V . For further information see product SPC. Prescription decisions are for the person issuing the prescription alone. Use medicines responsibly. www.noah.co.uk/responsible. For further information contact: Dechra, Sansaw Business Park, Hadnall, Shrewsbury, Shropshire SY4 4AS. Tel: +44 (0)1939 211200 www.dechra.co.uk. Registered Office: 24 Cheshire Avenue, Cheshire Business Park, Lostock Graham, Northwich CW9 7UA. Registered in England and Wales, Company Registration No. 5385888. Dechra Veterinary Products Limited is a trading business of Dechra Pharmaceuticals Limited.}